Home Cart Sign in  
Chemical Structure| 1452-63-7 Chemical Structure| 1452-63-7

Structure of Picolinohydrazide
CAS No.: 1452-63-7

Chemical Structure| 1452-63-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1452-63-7 ]

CAS No. :1452-63-7
Formula : C6H7N3O
M.W : 137.14
SMILES Code : O=C(NN)C1=NC=CC=C1
MDL No. :MFCD00059782
InChI Key :BAQLNPIEFOYKNB-UHFFFAOYSA-N
Pubchem ID :255881

Safety of [ 1452-63-7 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P280-P305+P351+P338-P310

Computational Chemistry of [ 1452-63-7 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 2
Num. H-bond acceptors 3.0
Num. H-bond donors 2.0
Molar Refractivity 35.13
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

68.01 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.14
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.83
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.31
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.47
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.27
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-0.15

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.48
Solubility 45.5 mg/ml ; 0.332 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.12
Solubility 104.0 mg/ml ; 0.762 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.64
Solubility 3.17 mg/ml ; 0.0231 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.73 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.38

Application In Synthesis of [ 1452-63-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1452-63-7 ]

[ 1452-63-7 ] Synthesis Path-Downstream   1~5

  • 2
  • [ 1452-63-7 ]
  • [ 103854-64-4 ]
  • C17H14N4O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
74% In ethanol; for 1h;Reflux; Compound 2 (200 mg, 1.156 mmol) and picolinohydrazide (3) (190 mg, 1.387 mmol) were dissolved in 25 mL of absolute ethanol, the solution was heated to reflux and stirred for 1 h. After cooled to room temperature, the pale yellow precipitates formed was collected by filtration, which was washed with ethanol and dried under vacuum to give 1 in 74% yield. mp 182.5-183 C. 1H NMR (400 MHz, DMSO-d6) δ 12.69 (s, 1H), 8.77 (s, 1H), 8.72 (d,1H, J = 4.4 Hz), 8.33 (d, 1H, J = 4.8 Hz), 8.13 (t, 2H, J = 9.2Hz), 8.05 (t, 1H, J = 7.2 Hz), 7.67 (dd, 1H, J1 = 6.8 Hz, J2 =5.2 H), 7.54-7.48 (m, 2H), 7.20 (d, 1H, J = 6.8 Hz), 3.96 (s,3H). 13C NMR (100 MHz, DMSO-d6) δ 161.35, 155.58, 152.93, 149.78, 149.52, 149.02, 139.51, 138.55, 136.93, 129.40, 128.26, 127.67, 123.45, 119.82, 118.37, 109.36,56.02. HRMS (ESI+) cacld for C17H14N4O2Na: 329.1014, found: m/z 329.1017 [M+Na]+.
  • 3
  • [ 1452-63-7 ]
  • [ 87220-68-6 ]
  • 2-(9-phenyl-9H-carbazole-3-yl)-5-(pyridin-2-yl)-1,3,4-oxadiazole [ No CAS ]
YieldReaction ConditionsOperation in experiment
39.9% In ethanol;Reflux; 9-Phenyl-9H-carbazole-3-carbaldehyde (2.71 g, 10 mmol) was added to the reaction flask and2-pyridinecarboxylic acid hydrazide (1.37 g, 10 mmol) followed by 120 mL of ethanol,The reaction was heated and stirred at reflux overnight. After cooling to room temperature,Slowly pour the reaction mixture into 500 mL of deionized water, and let it stand for 2 minutes after stirring for 10 minutes.Filter off and collect the white solid. The resulting white cake is in turn deionized water andEthanol was washed and placed in a vacuum oven at 50C for 24 hours.The dried intermediate product was placed in a single-mouth reaction flask and 70 mL of acetonitrile was added sequentially.30mL 1,4-dioxane and 150mL sodium hypochlorite solution,Stir for 30 min at room temperature. Pour the reaction slowly into 500mLDeionized water and extracted with dichloromethane (150 mL x 3).The organic phases were combined and washed with deionized water (200 mL x 3).The resulting organic phase was dried over anhydrous magnesium sulfate and concentrated.Column chromatography using ethyl acetate and petroleum ether as eluents gives the product L3 as a white solid.(1.55 g, 3.99 mmol), yield 39.9%.
  • 4
  • [ 1452-63-7 ]
  • [ 7113-10-2 ]
  • 2-phenyl-N′-picolinoylthiazole-4-carbohydrazide [ No CAS ]
  • 5
  • [ 1452-63-7 ]
  • [ 39067-29-3 ]
  • N′-picolinoyl-2-(pyridin-3-yl)thiazole-4-carbohydrazide [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1452-63-7 ]

Amides

Chemical Structure| 1452-77-3

A226558 [1452-77-3]

2-Pyridinecarboxamide

Similarity: 0.90

Chemical Structure| 956386-24-6

A303056 [956386-24-6]

6-Hydroxypicolinohydrazide

Similarity: 0.83

Chemical Structure| 1254073-41-0

A161543 [1254073-41-0]

5-Fluoropicolinohydrazide

Similarity: 0.82

Chemical Structure| 50608-99-6

A152128 [50608-99-6]

3-Aminopicolinamide

Similarity: 0.82

Chemical Structure| 145255-19-2

A184798 [145255-19-2]

5-Aminopyridine-2-carboxamide

Similarity: 0.80

Hydrazides

Chemical Structure| 956386-24-6

A303056 [956386-24-6]

6-Hydroxypicolinohydrazide

Similarity: 0.83

Chemical Structure| 1254073-41-0

A161543 [1254073-41-0]

5-Fluoropicolinohydrazide

Similarity: 0.82

Chemical Structure| 69583-00-2

A563218 [69583-00-2]

2-(Pyridin-4-yl)acetohydrazide

Similarity: 0.74

Chemical Structure| 39513-54-7

A166696 [39513-54-7]

Pyrimidine-4-carbohydrazide

Similarity: 0.73

Amines

Chemical Structure| 1452-77-3

A226558 [1452-77-3]

2-Pyridinecarboxamide

Similarity: 0.90

Chemical Structure| 956386-24-6

A303056 [956386-24-6]

6-Hydroxypicolinohydrazide

Similarity: 0.83

Chemical Structure| 1254073-41-0

A161543 [1254073-41-0]

5-Fluoropicolinohydrazide

Similarity: 0.82

Chemical Structure| 50608-99-6

A152128 [50608-99-6]

3-Aminopicolinamide

Similarity: 0.82

Chemical Structure| 145255-19-2

A184798 [145255-19-2]

5-Aminopyridine-2-carboxamide

Similarity: 0.80

Hydrazines

Chemical Structure| 956386-24-6

A303056 [956386-24-6]

6-Hydroxypicolinohydrazide

Similarity: 0.83

Chemical Structure| 1254073-41-0

A161543 [1254073-41-0]

5-Fluoropicolinohydrazide

Similarity: 0.82

Chemical Structure| 69583-00-2

A563218 [69583-00-2]

2-(Pyridin-4-yl)acetohydrazide

Similarity: 0.74

Chemical Structure| 39513-54-7

A166696 [39513-54-7]

Pyrimidine-4-carbohydrazide

Similarity: 0.73

Related Parent Nucleus of
[ 1452-63-7 ]

Pyridines

Chemical Structure| 1452-77-3

A226558 [1452-77-3]

2-Pyridinecarboxamide

Similarity: 0.90

Chemical Structure| 956386-24-6

A303056 [956386-24-6]

6-Hydroxypicolinohydrazide

Similarity: 0.83

Chemical Structure| 1254073-41-0

A161543 [1254073-41-0]

5-Fluoropicolinohydrazide

Similarity: 0.82

Chemical Structure| 50608-99-6

A152128 [50608-99-6]

3-Aminopicolinamide

Similarity: 0.82

Chemical Structure| 145255-19-2

A184798 [145255-19-2]

5-Aminopyridine-2-carboxamide

Similarity: 0.80